We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
Cap. Flow
+$512M
Cap. Flow %
1.04%
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$23.3M
2
BDX icon
Becton Dickinson
BDX
+$18.4M
3
AMZN icon
Amazon
AMZN
+$16.1M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$15.4M
5
JNJ icon
Johnson & Johnson
JNJ
+$14.6M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$48.1M
2
LVLT
Level 3 Communications Inc
LVLT
+$27.7M
3
KITE
Kite Pharma, Inc.
KITE
+$10.7M
4
PRXL
Parexel International Corp
PRXL
+$10.3M
5
CELG
Celgene Corp
CELG
+$10.2M

Sector Composition

Rank Sector Weight
1 Financials 16.9%
2 Technology 16.24%
3 Healthcare 13.01%
4 Industrials 10.83%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVRS
2801
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$70K ﹤0.01%
69,491
-13,752
-17% -$15.6K
ICON
2802
DELISTED
Iconix Brand Group, Inc.
ICON
$69K ﹤0.01%
5,331
-5,371
-50% -$152K
MFG icon
2803
Mizuho Financial
MFG
$120B
$68K ﹤0.01%
18,637
-640
-3% -$2.31K
NMR icon
2804
Nomura Holdings
NMR
$28.3B
$67K ﹤0.01%
11,585
-631
-5% -$3.65K
ARAV
2805
DELISTED
Aravive, Inc. Common Stock
ARAV
$66K ﹤0.01%
5,032
-1,013
-17% -$13K
VIVE
2806
DELISTED
VIVEVE MED INC
VIVE
$65K ﹤0.01%
13
– –
GNE icon
2807
Genie Energy
GNE
$370M
$64K ﹤0.01%
14,672
-400
-3% -$2.11K
ABCD
2808
DELISTED
Cambium Learning Group, Inc.
ABCD
$64K ﹤0.01%
11,299
+10
+0.1% +$60
IMDZ
2809
DELISTED
Immune Design Corp.
IMDZ
$64K ﹤0.01%
16,398
-3,471
-17% -$18.9K
WG
2810
DELISTED
Willbros Group
WG
$59K ﹤0.01%
41,878
-7,802
-16% -$16.3K
NDLS icon
2811
Noodles & Co
NDLS
$95.1M
$53K ﹤0.01%
1,256
– –
SHLD
2812
DELISTED
Sears Holding Corporation
SHLD
$52K ﹤0.01%
14,459
-2,119
-13% -$10.5K
AST
2813
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$52K ﹤0.01%
23,093
– –
MTNB icon
2814
Matinas BioPharma
MTNB
$1.91M
$50K ﹤0.01%
858
-175
-17% -$11.3K
KODK icon
2815
Kodak
KODK
$809M
$49K ﹤0.01%
15,738
-3,100
-16% -$14.3K
NH
2816
DELISTED
NantHealth, Inc
NH
$48K ﹤0.01%
1,059
-6
-0.6% -$318
JONE
2817
DELISTED
Jones Energy, Inc.
JONE
$47K ﹤0.01%
2,157
– –
NVLN
2818
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$42K ﹤0.01%
13,445
-2,703
-17% -$13K
NYRT
2819
DELISTED
New York REIT, Inc.
NYRT
$40K ﹤0.01%
1,010
– –
OMNT
2820
DELISTED
Ominto, Inc. Common Stock
OMNT
$38K ﹤0.01%
11,165
– –
RVLT
2821
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$37K ﹤0.01%
11,330
– –
RSYS
2822
DELISTED
Radisys Corp
RSYS
$36K ﹤0.01%
35,490
-5,935
-14% -$6.34K
RAS
2823
DELISTED
RAIT Financial Trust
RAS
$34K ﹤0.01%
91,422
-16,049
-15% -$7.25K
AQMS icon
2824
Aqua Metals
AQMS
$9.78M
$32K ﹤0.01%
75
-15
-17% -$11.3K
GNCA
2825
DELISTED
Genocea Biosciences, Inc.
GNCA
$28K ﹤0.01%
3,046
-736
-19% -$7.4K
111 112
113
114 115

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
  • RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
  • RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
  • RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
  • RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.

Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.